MW3982A1 - Pharmaceutical formulations comprising human insulin,human c-peptide,and human proinsulin - Google Patents

Pharmaceutical formulations comprising human insulin,human c-peptide,and human proinsulin

Info

Publication number
MW3982A1
MW3982A1 MW39/82A MW3982A MW3982A1 MW 3982 A1 MW3982 A1 MW 3982A1 MW 39/82 A MW39/82 A MW 39/82A MW 3982 A MW3982 A MW 3982A MW 3982 A1 MW3982 A1 MW 3982A1
Authority
MW
MALAWI
Prior art keywords
human
peptide
pharmaceutical formulations
proinsulin
insulin
Prior art date
Application number
MW39/82A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MW3982A1 publication Critical patent/MW3982A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MW39/82A 1981-08-27 1982-08-24 Pharmaceutical formulations comprising human insulin,human c-peptide,and human proinsulin MW3982A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671681A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
MW3982A1 true MW3982A1 (en) 1984-06-13

Family

ID=23143244

Family Applications (1)

Application Number Title Priority Date Filing Date
MW39/82A MW3982A1 (en) 1981-08-27 1982-08-24 Pharmaceutical formulations comprising human insulin,human c-peptide,and human proinsulin

Country Status (18)

Country Link
JP (1) JPS5846026A (xx)
AU (1) AU551734B2 (xx)
BE (1) BE894187A (xx)
CA (1) CA1176159A (xx)
CH (1) CH650680A5 (xx)
DE (1) DE3232035A1 (xx)
FR (1) FR2511868B1 (xx)
GB (1) GB2104381B (xx)
IL (1) IL66612A (xx)
IT (1) IT1153183B (xx)
LU (1) LU84357A1 (xx)
MW (1) MW3982A1 (xx)
NL (1) NL8203313A (xx)
NZ (1) NZ201685A (xx)
PH (1) PH18640A (xx)
SE (1) SE8204872L (xx)
ZA (1) ZA826160B (xx)
ZW (1) ZW17682A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652548A (en) * 1981-08-27 1987-03-24 Eli Lilly And Company Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
JPS62222379A (ja) * 1986-03-25 1987-09-30 Mutoh Ind Ltd コンピュータグラフィックスにおける隠線・隠面処理方法
US9389582B2 (en) 2014-06-02 2016-07-12 Lexmark International, Inc. Replaceable unit for an image forming device having magnets of varying angular offset for toner level sensing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
CA1176159A (en) 1984-10-16
IT1153183B (it) 1987-01-14
PH18640A (en) 1985-08-23
CH650680A5 (de) 1985-08-15
LU84357A1 (fr) 1983-02-28
FR2511868A1 (fr) 1983-03-04
NL8203313A (nl) 1983-03-16
JPS5846026A (ja) 1983-03-17
SE8204872L (sv) 1983-02-28
SE8204872D0 (sv) 1982-08-25
DE3232035A1 (de) 1983-03-10
ZA826160B (en) 1984-04-25
AU551734B2 (en) 1986-05-08
NZ201685A (en) 1985-09-13
BE894187A (fr) 1983-02-24
FR2511868B1 (fr) 1986-05-09
AU8759782A (en) 1983-03-03
ZW17682A1 (en) 1982-11-24
IT8223018A0 (it) 1982-08-27
IL66612A (en) 1985-11-29
GB2104381B (en) 1984-12-05
GB2104381A (en) 1983-03-09

Similar Documents

Publication Publication Date Title
AU7914581A (en) Human proinsulin, insulin, preparation thereof
IL79887A (en) Human insulin analogues,their preparation and pharmaceutical compositions containing them
GB2105191B (en) Pharmaceutical formulations comprising human insulin and human proinsulin
GB2104382B (en) Pharmaceutical formulations comprising human insulin and human c-peptide
GB2104381B (en) Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin
GB2104380B (en) Human proinsulin pharmaceutical formulations
ZA854330B (en) Insulin formulations,processes for their preparation and their use
IE822063L (en) Insulin, proinsulin and c-peptide formulations
JO1238B1 (en) Pharmacy formulations include human insulin, human peptide-C and the human insulin component
IE812104L (en) Novel insulin formulations based on human insulin
IE822065L (en) Insulin and proinsulin formulations
JO1209B1 (en) Pharmacy formulations that include human insulin and the human insulin component.
JPS57209227A (en) Insulin medicine and manufacture